Our Locations

Corporate Offices/Administration
1 Cragwood Road, Suite 203
South Plainfield, NJ 07080 USA
Primary Mailing Address:,
R&D, Labs, Manufacturing
300 Corporate Court, Suite B
South Plainfield, NJ 07080 USA
e-Contacts
908-444-4660 direct
908-444-4661 fax
info@prolongpharma.com
www.prolongpharma.com
Prolong Pharmaceuticals Presents Data on Unique “Un-Sickling” In Vitro Activity Observed in Sickle Cell Investigational Drug SANGUINATE™
Prolong Pharmaceuticals’ Flagship Product SANGUINATE™ Granted Orphan Drug Designation by the FDA
Prolong Expands Operations (& Potential for Success)
Prolong Pharmaceuticals Moves Into New Headquarters
Father of PEGylation to Receive Dr. Sol J. Barer Award at Gateway Gala, BioNJ’s 22st Annual Dinner Meeting, Networking Event and Innovation Celebration
Use of SANGUINATE in encephalopathy from severe sickle cell disease
Strategic Approach Needed for International Clinical Trials
Sickle Cell Disease In Three Acts
Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
Prolong’s approach: Taking on multiple diseasesCompany confident Sanguinate can be difference-maker